Our mission is to advance the understanding, diagnosis, and treatment of bronchiectasis through high-quality clinical research and cutting-edge translational research that bridges the gap between laboratory discoveries and real-world patient care.

By leveraging a collaborative, multidisciplinary approach, EMBARC conducts a breadth of research including clinical trials, inflammatory biomarker studies, and translational investigations to uncover novel therapeutic strategies and improve patient outcomes. 

Explore our latest research initiatives, ongoing studies, and opportunities for collaboration as we work to transform bronchiectasis care through innovation and scientific excellence.